圣地亚哥共识:咽喉部症状与咽喉反流性疾病
该共识由28人国际多学科工作组制定,采用RAND适当性方法投票,≥80%同意纳入推荐。共识提出咽喉部症状(LPS)不等同于咽喉反流性疾病(LPRD),后者需客观反流证据;并根据是否伴食管反流症状分层推荐诊断与治疗路径。
要点
- LPS指可能由反流诱发的咳嗽、声嘶、清嗓、咽部痰多和咽痛,不等同于LPRD。
- LPRD诊断需客观反流证据,喉镜所见 alone 不能诊断LPRD。
- LPS伴食管反流症状时可经验性抑酸±藻酸盐治疗;孤立LPS或需升级治疗时需内镜和反流监测。
核心结论
- 圣地亚哥共识提供了评估和管理LPS与LPRD的现代跨学科诊疗范式。
- LPS不等同于LPRD,LPRD需客观反流证据。
研究设计与样本
- 28人国际跨学科工作组制定实用声明,涵盖定义/术语、初始诊断评估、反流监测、治疗试验、行为因素与治疗、风险分层等领域。
- 文献综述指导声明制定,经虚拟/线下会议展示,每项声明按RAND适当性方法进行2轮或以上投票,≥80%同意且达到适当性的声明纳入推荐。
主要发现
- LPS指可能由反流诱发的食管外症状,包括咳嗽、发声改变、清嗓、咽部痰多和咽痛。
- LPRD指有LPS且有客观反流证据的患者。
- 喉镜检查有助于评估非反流性咽喉部病变,但仅凭喉镜所见不能诊断LPRD。
- LPS患者应分为伴或不伴食管反流症状两类。
- 24小时pH-阻抗监测和96小时无线pH监测是两种推荐的反流监测方式,互不排斥,在LPS评估中各有不同作用。
关键数值与推荐
- 声明达到适当性且≥80%同意方纳入推荐。
- LPS伴食管反流症状时,生活方式调整和抑酸±藻酸盐经验性试验是适当的。
- 症状持续、孤立性LPS或需升级至侵入性抗反流治疗时,需上消化道内镜和动态反流监测以诊断LPRD。
- 推荐24小时pH-阻抗和96小时无线pH监测两种动态反流监测方式。
- 喉部高反应性和过度警觉常参与LPS和LPRD表现,对喉部重校准治疗和神经调节剂有反应。
临床怎么用
- LPS患者应分类为伴或不伴食管反流症状。
- 伴食管反流症状时,可进行生活方式调整和抑酸±藻酸盐经验性试验。
- 症状持续、孤立性LPS或需升级至侵入性抗反流治疗时,应行上消化道内镜和动态反流监测。
- 喉镜用于评估非反流性咽喉部病变,不能单独诊断LPRD。
- 喉部高反应性和过度警觉可考虑喉部重校准治疗和神经调节剂。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The term laryngopharyngeal reflux (LPR) is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. The aim of this initiative was to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines. METHODS: A 28-member international interdisciplinary working group developed practical statements within the following domains: definition/terminology, initial diagnostic evaluation, reflux monitoring, therapeutic trials, behavioral factors and therapy, and risk stratification. Literature reviews guided statement development and were presented at virtual/in-person meetings. Each statement underwent 2 or more rounds of voting per the RAND Appropriateness Method; statements reaching appropriateness with ≥80% agreement are included as recommendations. RESULTS: The term laryngopharyngeal symptoms (LPS) applies to aerodigestive symptoms with potential to be induced by reflux and include cough, voice change, throat clearing, excess throat phlegm, and throat pain. Laryngopharyngeal reflux disease (LPRD) refers to patients with LPS and objective evidence of reflux. Importantly, the presence of LPS does not equate to LPRD. Laryngoscopy has value in assessing for nonreflux laryngopharyngeal processes, but laryngoscopic findings alone cannot diagnose LPRD. LPS patients should be categorized as with or without concurrent esophageal reflux symptoms. While lifestyle modification and empiric trials of acid suppression ± alginates are appropriate when esophageal reflux symptoms coexist, upper endoscopy and ambulatory reflux monitoring are required for LPRD diagnosis when symptoms persist, when LPS is isolated, or when management needs to be escalated to include invasive antireflux management. The two recommended ambulatory reflux monitoring modalities, 24-hour pH-impedance and 96-hour wireless pH monitoring, are not mutually exclusive with distinct roles for the evaluation of LPS. Laryngeal hyperresponsiveness and hypervigilance commonly contribute to both LPS and LPRD presentations and are responsive to laryngeal recalibration therapy and neuromodulators. DISCUSSION: The San Diego Consensus represents the formal modern-day interdisciplinary care paradigm to evaluate and manage LPS and LPRD.
引用
- Yadlapati R, Weissbrod P, Walsh E, et al. The San Diego Consensus for Laryngopharyngeal Symptoms and Laryngopharyngeal Reflux Disease. Am J Gastroenterol. 2025. PMID: 40197644. doi:10.14309/ajg.0000000000003482
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。